NOVELION THERAPEUTICS INC's ticker is NVLN and the CUSIP is 67001K103. A total of 1 filers reported holding NOVELION THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $41,000 | +13.9% | 11,796 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $36,000 | -55.0% | 11,600 | +1.5% | 0.00% | -50.0% |
| Q3 2017 | $80,000 | -28.6% | 11,432 | -5.5% | 0.00% | -33.3% |
| Q2 2017 | $112,000 | -13.8% | 12,096 | +0.1% | 0.01% | -25.0% |
| Q1 2017 | $130,000 | +12.1% | 12,081 | -12.0% | 0.01% | +14.3% |
| Q4 2016 | $116,000 | – | 13,729 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Freedom Investment Management, Inc. | 13,729 | $116,000 | 0.01% |